The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment.
The kidney function can be assessed by a number of methods. The urinary excretion of enzymes, in particular N-acetyl-beta-D-glucosaminidase (NAG), is considered a relatively simple, cheap, fast and non-invasive method in the detection and follow-up of renal tubular function under various conditions. The determination of urinary NAG provides a very sensitive and reliable indicator of renal damage, such as injury or dysfunction due to diabetes mellitus, nephrotic syndrome, inflammation, vesicoureteral reflux, urinary tract infection, hypercalciuria, urolithiasis, nephrocalcinosis, perinatal asphyxia, hypoxia, hypertension, heavy metals poisoning, treatment with aminoglycosides, valproate, or other nephrotoxic drugs. This paper gives an overview of the current use of urinary NAG in the detection of renal injury.
Skálová
Sylva
S
Department of Pediatrics, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic. skalova.s@seznam.cz
D000118:Acetylglucosaminidase / Q000652:urine*; D015415:Biomarkers / Q000652:urine; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis*; D007684:Kidney Tubules / Q000503:physiopathology
D015415:Biomarkers; D000118:Acetylglucosaminidase